NIH to Secretly Review Research Grants Again
Published Date: 7/22/2026
Notice
Summary
The Center for Scientific Review is holding several closed virtual meetings in August 2026 to review and evaluate important grant and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding to fight antibiotic resistance, support schizophrenia research, and boost medical tech. If you’re involved in these fields, keep an eye on these dates—they could impact future research dollars and projects.
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Closed Review: CC4CARB Contract
On August 18, 2026 from 11:00 a.m. to 2:20 p.m., the NIH Center for Scientific Review will hold a closed virtual meeting to review and evaluate contract proposals for the Chemistry Center for Combating Antibiotic-Resistant Bacteria (CC4CARB). The meeting is closed under 5 U.S.C. 552b(c)(4) and (c)(6) to protect confidential trade secrets and personal information.
Closed Review: AMP Schizophrenia U24
On August 26, 2026 from 1:00 p.m. to 9:00 p.m., the NIH Center for Scientific Review will hold a closed virtual meeting to review and evaluate grant applications for RFA-MH-27-205: Single Source Accelerating Medicines Partnership Schizophrenia (AMP SCZ) Data Processing, Analysis, and Coordination Center (U24). The meeting will be closed under 5 U.S.C. 552b(c)(4) and (c)(6) to protect confidential commercial information and personal data.
Closed Review: Blueprint MedTech Translator
On August 27, 2026 from 12:00 p.m. to 2:00 p.m., the NIH Center for Scientific Review will hold a closed virtual PAR panel meeting to review and evaluate grant applications for the Blueprint MedTech Translator (Clinical Trial Optional). The meeting is closed under 5 U.S.C. 552b(c)(4) and (c)(6) to prevent disclosure of trade secrets and personal information.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-14666, National Institute of Neurological Disorders and Stroke; Notice of Meeting
The National Institute of Neurological Disorders and Stroke is hosting a free, virtual meeting on August 24, 2026, to talk about Parkinson’s disease research, care, and services. This meeting affects people with Parkinson’s, their families, and organizations working on the disease, as it will share updates and plan a federal list of Parkinson’s programs. Public comments are welcome until August 10, giving everyone a chance to join the conversation and help shape future efforts.
2026-14347, Government Owned Invention Available for License: Method of Manufacturing Papilloma Infiltrating Lymphocyte (PIL) Cell Therapy Products as a Treatment for Patients With Chronic Viral Infection(s)
The National Cancer Institute has created a new way to make special immune cells called PILs that can fight chronic HPV infections causing painful growths in the throat and genital areas. This new cell therapy could reduce the need for repeated surgeries, improving patients’ lives and cutting healthcare costs. Researchers are now looking for partners to help develop and license this promising treatment soon.
2026-14346, Government Owned Invention Available for License: Selective Expansion of Engineered TCR-T Cells for Use in Adoptive Cell Immunotherapy
The National Cancer Institute has invented a cool new way to grow special immune cells called TCR-T cells that can better fight cancer. This method helps companies make more powerful, targeted cell therapies by boosting the right cells and cutting out the extras. If you’re in biotech or cancer treatment, this is your chance to license a game-changing tool that could speed up cancer cures and bring new treatments to patients faster.
2026-14242, National Institute on Minority Health and Health Disparities; Notice of Partially Closed Meeting
The National Institute on Minority Health and Health Disparities is holding a virtual meeting on August 31, 2026, to discuss important health topics and review grant applications. The first part of the meeting is open to the public and will be streamed online, while the last hour is closed to protect private info and trade secrets. This meeting affects researchers and communities focused on minority health and could influence future funding decisions.
2026-14133, Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering new, powerful antibodies for licensing that help the immune system fight cancer better by releasing its natural brakes. This opportunity is perfect for companies ready to bring cutting-edge cancer treatments to market faster, with some international patent options available. Interested parties should act soon to explore this exciting tech and start making a difference—and money!
2026-14003, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review and decide on important research grant applications. These meetings keep sensitive info private, protecting ideas and personal details. Scientists applying for grants and the research community will feel the impact as funding decisions get made on time.
Previous / Next Documents
Previous: 2026-14750, Self-Regulatory Organizations; Nasdaq GEMX, LLC; Notice of Filing and Immediate Effectiveness of Proposed Rule Change To Amend Rule General 8 Regarding Intrafirm Cabinet Connectivity
Nasdaq GEMX is updating its rules to clearly include a new type of fiber connection called non-contiguous intrafirm cabinet connectivity and is changing the fees for this service. This affects firms using GEMX’s network connections inside their trading setups. The new rule is effective immediately, so firms should check the updated fees and plan accordingly.
Next: 2026-14754, PNGT Rail, LLC-Acquisition Exemption-Rail Line of Franklin Storage, LP at WCN Drive Transload Facility, Chambersburg, PA.
PNGT Rail, LLC is set to take over and operate a short rail line at a transload facility in Chambersburg, PA, currently leased by Franklin Storage, LP. This change means PNGT will handle shipments of materials like cardboard and lumber, working with Norfolk Southern Railway. The deal is official as of July 6, 2026, and won’t impact PNGT’s revenue limits or cause big money changes.